Mimosine (MIM) and aphidicolin (APH) are two agents frequently used in tissue culture-based experiments to achieve cell synchronization at late G1 and S phases. Following MIM or APH treatment of human cancer cell lines, a reversible growth arrest in late G1 and S phases of the cell cycle was correlated with moderate increases in p53 and p21 protein levels. Both p53-dependent and -independent increases in p21 were observed following treatment with either agent. However, a striking increase in p21 protein levels and a continuous elevation in both p53 and p21 protein levels were observed over 48 h after cells re-entered the cell cycle following the chemicallyinduced synchronization. In addition, the increase in p21 protein levels typically seen following treatment of cells with DNA damaging agents, was enhanced when cells were treated with genotoxic agents following MIM or APH synchronization. These ®ndings suggest that caution should be exercised when interpreting results from experiments using cell synchronization agents, in particular, studies designed to investigate p53-and p21-regulatory pathways.
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Keywords: p53; p21; cell cycle synchronization; mimosine; aphidicolin Mimosine (MIM) and aphidicolin (APH) are commonly used as potent and reversible late G1 and S phase blockers of the cell cycle. Several modes of action for these two compounds have been proposed, however, the molecular mechanisms are not completely understood. Aphidicolin is a known inhibitor of DNA polymerases (Wang, 1991) . Mimosine is a plant amino acid thought to block DNA synthesis by decreasing cellular dNTP concentrations through regulation of ribonucleotide reductase (Dai et al., 1994; Gilbert et al., 1995) . Previously, many studies have used these agents to synchronize cells to examine cell cycle regulation of gene expression and protein activity. However, little attention has been given to the direct eect of these agents or the eect of cell cycle re-entry following the induction of arrest by these agents on checkpoint regulatory proteins.
The mammalian cell cycle maintains internal check points at which cells arrest when previous events have not been completed in response to external signals (Hartwell and Weinert, 1989) . Numerous studies have demonstrated a role for the tumor suppressor p53 in G1 cell cycle checkpoint (Kastan and Kuerbitz, 1995; Agarwal et al., 1995) and also in G2/M checkpoint (Stewart et al., 1995; Agarwal et al., 1995) . In cells maintaining a normal p53 gene, p53 protein levels are increased as a response to DNA damage (Kastan et al., 1991; Kuerbitz et al., 1992) and this is correlated with growth arrest. The tumor suppressive function of p53 is thought to be linked to its ability to function as a sequence-speci®c transcriptional activator of a number of genes, including p21 (ElDeiry et al., 1993) . p21 is a cyclin-dependent kinase inhibitor (Kato and Sherr, 1993; Harper et al., 1993) and when overexpressed can also induce growth arrest (El-Deiry et al., 1993) . Several studies have demonstrated that p21 mRNA and protein levels are elevated in a p53-dependent manner following treatment of cells with genotoxic agents Dulic et al., 1994) , although additional studies have shown regulation of p21 that is p53-independent (Steinman et al., 1994; Macleod et al., 1995; Zhang et al., 1995; Parker et al., 1995; Russo et al., 1995) . In this study, we demonstrate that treatment of cells with either APH or MIM resulted in elevation of p53 and p21 protein levels. More signi®cantly, the elevated levels of p53 and p21 protein were maintained over a 48 h time period following release of cells from chemically-induced synchronization.
Initially, we determined the kinetics of cell cycle release following treatment of the human colorectal cancer cell line RKO with MIM (100 mM) or APH (12 mM). Cell cycle progression was evaluated by¯ow cytometric analysis. Following a 24 h MIM or APH treatment, a decrease in the percentage of RKO cells in the G2/M phase and an increase in the percentage of cells in the G1 and S phases of the cell cycle were observed ( Figure 1a) .
The cell cycle blockade induced by MIM or APH was released by washing the cell monolayers and incubating the cultures in fresh medium. In order to determine the kinetics of release, experiments were conducted in which cell cycle distribution was analysed at distinct times following removal of MIM (Figure 1b) or APH ( Figure 1c ). Over time following release from the MIM block, cell populations in G1 phase decreased in parallel with a S phase increase. By 12 h postrelease, over 80% of the cells were in S followed by a 50% increase in the G2/M phase population at 15 h (Figure 1b) . A similar pattern of cell cycle progression was observed following APH treatment. By 5 ± 10 h post APH release, 475% of the cell population was in S phase and by 12 ± 15 h, 460% of the cell population was in G2/M (Figure 1c ). We performed dose-response experiments with both agents and obtained similar Figure 1 MIM and APH induction of G1 and S phase blocks in RKO cells and kinetics of release. RKO cells were incubated in the presence or absence of MIM (100 mM) and APH (12 mM) for 24 h and cells harvested for¯ow cytometric determination (a). Data presented are representative of at least three independent experiments. Kinetics of cell cycle release following MIM (b) and APH (c) blocks are shown. G1, &; S,~; G2/M, *. RKO cells were incubated with MIM or APH at 378C for 24 h, washed two times with growth medium and incubated in drug-free medium for the times indicated. RKO cells were grown in McCoy's 5A medium supplemented with 10% bovine serum, 50 unit/ml penicillin and 50 mg/ml streptomycin. Cells were seeded 24 h or 48 h before chemical treatment, and were 60 ± 80% con¯uent at the time of treatment. MIM (10 mM) and APH (15 mM) stock solution were made with PBS and methanol, respectively, and diluted with medium prior to application. ADR or MDA was directly dissolved in a fresh medium and added to cultures immediately. Flow cytometric determination of cell-cycle was performed by staining the DNA with propidium iodide. Brie¯y, following indicated treatment, cells were trypsinized and washed with ice-cold PBS and ®xed in 70% ethanol (7208C for at least 1 h). Cells were resuspended in PBS, incubated with RNase (1 mg/ml) at room temperature for 15 min, and stained with propidium iodide (50 mg/ml) at room temperature for 30 min. Cell-cycle determination was performed using a Becton-Dickinson¯uorescence-activated cell Sorting (FACScan)¯ow cytometer p53 and p21 increase after cell cycle synchronization C Ji et al kinetics of synchronization and release with dosages of 100 mM to 400 mM MIM and 8 mM to 24 mM APH (data not shown).
To examine the eect of synchronization agents on p53 and p21 protein levels, RKO cells were treated with MIM and APH for 24 h followed by release for increasing periods of time over a 48 h time course. For a positive control, in parallel experiments, RKO were treated with the following genotoxic agents: adriamycin (ADR), or malondialdehyde (MDA) a product of lipid biosynthesis and eicosanoid biosynthesis (Janero, 1990) . Treatment of cells with either ADR or MDA has been demonstrated to induce DNA damage and increase both p53 and p21 protein levels Chuan et al., 1997) . From each treatment condition, cell samples were divided for¯ow cytometric analysis (Figure 2a ) and Western analysis (Figure 2b) . Administration of ADR (0.4 mM) and MDA (1 mM) resulted in predominantly a G2/M phase arrest and a S and G2/M phase arrest, respectively. The cell cycle arrest induced by these agents was not reversible even after 48 h incubation in drug-free medium (Figure 2A ). Administration of MIM and APH resulted in cell cycle arrest at G1 and S phases and the arrest was reversed after agent withdrawal (Figure 2a ). Ten hours following MIM and APH withdrawal, cell populations moved from G1/S to S and G2/M phases. Whereas the cells appear to recover from MIM treatment, cells appeared to accumulate and arrest at G2/M following APH treatment.
Corresponding to these cell cycle progression changes, the level of p53 protein was signi®cantly increased. Twenty-four hours after MIM and APH treatment, the level of p53 protein was increased by all drugs in a dose-dependent manner (data not shown). After removal of the synchronization agents, only slight increases in p53 protein levels were observed. The increase in p53 protein levels during synchronization was likely due to post-translational stabilization of the protein as previously shown for other agents (Maltzman and Czyzyk, 1984) . p21 protein levels were not altered signi®cantly following a 24 h MIM treatment (100 mM or 250 mM) or lower dose APH treatment (12 mM) but increased moderately following 24 mM APH exposure. In contrast, the p21 protein levels were signi®cantly increased as early as 10 h after release from MIMand APH-induced cell cycle arrest (Figure 2b) . Further incubation for 24 h and 36 h post-treatment, resulted in even greater accumulation of p21 protein that began to decrease after 48 h of growth in drug-free medium. The increase in p21 protein levels correlated with an observed G2/M accumulation of cells, in particular following release from APH blockade. In addition, the increase in p21 protein is paralleled by an increase in p21 RNA levels (data not shown).
To determine if the observed increase in p21 protein was due to a p53-dependent mechanism, experiments were conducted with a human large cell lung carcinoma cell line, H1299, that has a homozygous deletion of the p53 gene. Following induction of a cell cycle block by a 24 h treatment of MIM (250 mM) or APH (12 mM), cells were washed and incubated in drug free medium for 2 h, and then cultured in the presence or absence of MDA (1 mM) or ADR (1.2 mM) for an additional 22 h. Cells were harvested and analyzed by¯o w cytometric analysis and Western analysis. Pro®les of cell cycle distribution and corresponding Western blots from the samples are shown in Figure 3a and Figure 3 H1299 cell cycle distribution and p53-independent expression of p21 protein following release from MIM or APH block. H-1299 cells were synchronized with MIM (250 mM) or APH (12 mM) for 24 h. Cells were washed twice to remove synchronization agents from the medium. Two hours after release from MIM or APH blockade, cells were incubated in the presence or absence of MDA (1 mM) or ADR (1.2 mM) for 22 h. Cells from the same sample were divided into two portions: (a) Flow cytometric analysis of cell cycle distribution as described in Figure  1 legend; and (b) Western blot analysis of p21 protein levels as described in Figure 2 legend. Control represents exponentially growing cells; MIM and APH represents cells that were treated with these agents for 24 h and released for 24 h; ADR and MDA represent cells that were treated with these agents for 22 h; MIM-MDA, APH-MDA, MIM-ADR, and APH-ADR represent cells treated with the synchronization agents for 24 h, washed and incubated for 2 h, followed by treatment with either ADR or MDA for 22 h p53 and p21 increase after cell cycle synchronization C Ji et al signi®cantly. Following synchronization induced by MIM, MDA blocked cells predominantly in S phase, whereas ADR blocked in G2/M phase. However, cells were blocked predominantly in S phase by ADR following synchronization by either agent. Interestingly, the cell samples that underwent a predominant G2 accumulation had parallel increases in p21 protein levels (Figure 3b , APH-MDA and MIM-ADR). In summary, during MIM-and APH-induced synchronization, p53 protein levels increased. The direct induction of p53 and p21 by MIM is consistent with previous studies (Lavin et al., 1994; Linke et al., 1996; Alpan and Pardee, 1996) . However, we determined that following release of cells from the MIM or APH block, a striking increase in p21 protein levels was evident. The increase in p21 protein levels was observed in parallel with an accumulation of cells in G2/M, and occurred by both p53-dependent and -independent pathways. In addition, the signi®cant alteration of p53 and p21 protein levels for 2 days following release from MIM-or APH-induced cell synchronization indicates that there may be potential misinterpretation in conclusions reached by studies that employ MIM and APH to block cell cycle progression. Thus, while these agents remain useful as tools for probing select cell cycle regulatory events or aspects of the DNA replication machinery, caution should be exercised in the interpretation of the results.
